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Abstract: Ultra-marathon running has enjoyed increasing popularity, with the number of master ultra-
marathon runners growing annually. This study presents a case of a 51-year-old highly experienced
long-distance runner (body mass: 65.1 kg, body height: 168 cm), who took part in a 48-h ultra-marathon
race held in 2010, but dropped out of the competition due to acute cardiac problems manifested after 16
h of running and having completed a distance of 129 km. Two weeks following the race, intense cardiac
examination was performed to explain the drop-out due to chest pain. A 12‑lead electrocardiogram, a
2D transthoracic echocardiography in 3 apical projections of the left ventricle, a computed tomography
of the chest, an invasive coronary angiography and a maximal oxygen uptake (VO<sub>2max</sub>)
test were performed. The 12-lead ECG revealed a negative T wave in III and aVF without morphological
abnormalities. The echocardiographic examinations presented a normal size and function of the heart
chambers, and a normal valvar structure and function (only trivial mitral and tricuspid regurgitation
was observed). The invasive coronary arteriography - due to an increased calcium score in the CT scan
- showed only a non-significant systolic dynamic narrowing in the eighth segment of the left anterior
descending artery due to a muscle bridge. The physical performance characteristics of the athlete and a
follow-up history of his athletic activity showed that the cardiac problems he had experienced during the
ultra-marathon race did not prevent him from being active in sport.
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Abstract
Ultra-marathon running has enjoyed increasing popularity, with the number of master ultra-marathon runners growing annually. This study presents 
a case of a 51-year-old highly experienced long-distance runner (body mass: 65.1 kg, body height: 168 cm), who took part in a 48-h ultra-marathon 
race held in 2010, but dropped out of the competition due to acute cardiac problems manifested after 16 h of running and having completed a distance 
of 129 km. Two weeks following the race, intense cardiac examination was performed to explain the drop-out due to chest pain. A 12-lead electrocar-
diogram, a 2D transthoracic echocardiography in 3 apical projections of the left ventricle, a computed tomography of the chest, an invasive coronary 
angiography and a maximal oxygen uptake (VO2max) test were performed. The 12-lead ECG revealed a negative T wave in III and aVF without morpho-
logical abnormalities. The echocardiographic examinations presented a normal size and function of the heart chambers, and a normal valvar structure 
and function (only trivial mitral and tricuspid regurgitation was observed). The invasive coronary arteriography – due to an increased calcium score in 
the CT scan – showed only a non-significant systolic dynamic narrowing in the eighth segment of the left anterior descending artery due to a muscle 
bridge. The physical performance characteristics of the athlete and a follow-up history of his athletic activity showed that the cardiac problems he had 
experienced during the ultra-marathon race did not prevent him from being active in sport. Int J Occup Med Environ Health. 2020;33(4)
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ter this drop-out (i.e., 2010–2019), the authors were able to 
present important and new aspects of the severity of long-
term health problems in ultra-marathon runners.
CASE PRESENTATION
Participant and ethical approval
In June 2010, a 51-year-old highly experienced long-dis-
tance runner (body mass: 65.1 kg, body height: 168 cm) 
took part in a 48-h ultra-marathon race organized by the 
Jerzy Kukuczka Academy of Physical Education in Kato-
wice. This was his 55th start in a running event on a track 
>42.195 km, during which he planned to improve his life 
record (370.381 km) achieved in 2000 during the Brno 
48-h indoor international endurance race. The study pro-
tocol conformed to the ethical guidelines of the World 
Medical Association’s Declaration of Helsinki and was ap-
proved by the Institutional Ethics Committee at the Jerzy 
Kukuczka Academy of Physical Education (decision No. 
1/2009). Consent to the processing of personal data was 
provided by all participants.
Characteristics of the race,  
study protocol and race results
The 48-h ultra-marathon race was held on a 3000-m oval 
walking  trail  situated  on  the  flat  outskirts  of  Katowice. 
The distance covered was estimated through automated 
counting of passages through an electronic gate set up at 
the trail. All competitors were allowed free (unrecorded) 
access to food (e.g., sandwiches, cookies, bananas, carbo-
hydrate energy bars) and liquids (e.g., water, sport bever-
ages, soft drinks and broth), and a small amount (<100 ml) 
of coffee every 8 h. Environmental conditions at the start 
of the race (12 a.m.) and after 12 h of running were good, 
with a temperature of 22°C and 15°C, and relative humid-
ity of 53% and 100%, respectively. Samples of venous 
and capillary blood were collected 3 h before the start of 
the competition, after 12 h of running and, in this case, 
consequent to a drop-out of the race due to acute chest 
INTRODUCTION
Ultra-marathon running, in which mainly master athletes 
compete, has enjoyed increasing popularity [1]. Ultra-
marathon races are mainly held as distance-limited [2] or 
time-limited [1] races. There is much evidence on the ben-
eficial effects of regular physical activity on the cardiovas-
cular system [3]. However, participation in a prolonged 
strenuous exercise such as an ultra-marathon race leads to 
severe metabolic stress [4], which may lead to a substan-
tially increased health risk evidenced by an altered car-
diac function and marked increases in blood markers of 
skeletal muscle and cardiac muscle damage [5], or even to 
a sudden cardiac death [6]. Most studies on physiological 
and metabolic effects of ultra-distance running have been 
conducted on successful finishers, while the metabolic pro-
file of non-finishers is described only in a few reports [7]. 
In fact, 48-h ultra-marathon races are rarely held [1] and 
very little scientific data exists for this kind of ultra-mar-
athon running, with 1 case report investigating pre-race 
preparation [8], 1 case report pacing during the race [9], 
and a field  study  investigating metabolic  changes during 
and after the race [10].
To the best of the authors’ knowledge, no case report has 
ever investigated the evaluation of acute chest pain during 
a 48-h ultra-marathon race in a master runner. In the pres-
ent case study, the authors describe a highly experienced 
ultra-marathon runner who had to stop after 16 h of run-
ning, during a 48-h ultra-marathon race held in 2010, due 
to acute chest pain. The primary intention was to examine 
metabolic changes during and after the race. However, 
the athlete was then also examined with regard to the rea-
sons for the acute chest pain. Extensive cardiac examina-
tion with a 12-lead electrocardiogram (ECG), a 2D trans-
thoracic echocardiography in 3 apical projections of the left 
ventricle, a computed tomography (CT) of the chest, an in-
vasive coronary angiography, and a maximal oxygen uptake 
(VO2max) test were performed after the race. With a long-
term follow-up history of his later sports achievements af-
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disease (CAD) in the competitor, the atherogenic index of 
plasma [AIP = log10(TG/HDL-C) with TG and HDL-C ex-
pressed in molar concentrations] [11] was calculated.
Cardiac examinations after the race
Two weeks following the race, spent first on passive and then 
on active recovery aimed to regain his physical and psycho-
logical well-being, the runner presented to the Cardiology 
Unit of the Medical University of Silesia for a follow-up 
consultation. During his 4-day stay in the hospital ward, 
targeted at finding the cause of the stenocardial symptoms 
that occurred during the ultra-marathon race after 16 h of 
continuous running, he was subjected to diagnostic proce-
dures. A CT of the chest was performed to evaluate car-
diac risk profiles and cardiac procedures (calcium scoring) 
(Toshiba Medical Systems Corporation, Otawara, Japan). 
A 12-lead ECG was performed to analyze heart rhythm and 
the ST-segment abnormalities. A resting 2D transthoracic 
echocardiography (TTE) in 3 apical projections of the left 
ventricle (LV) was performed using the Vivid system (GE 
Vingmed Ultrasound AS, Horten, Norway). Following 
the guidelines of the American Society of Echocardiogra-
phy, 4-, 2-, and 3-chamber examinations were performed.
The left ventricular end-diastolic diameter (LVEDd), the 
left ventricular end-systolic diameter (LVESd) and the right 
ventricular diastolic dimension (RVDd), were acquired us-
ing the Simpson method with the assumption that the cham-
bers are spherical and constitute the arithmetic mean of 
the indicated volumes in both the 4- and 2-chamber projec-
tions. The left ventricular ejection fraction (LVEF) consti-
tuted the ratio of the stroke volume and the left ventricu-
lar end-diastolic volume (LVEDV), and was calculated as 
the arithmetic mean of 3 subsequent measurements.
The left ventricular mass (LVM) and the left ventricular 
muscle mass index (LVMI) were calculated. The LVMI 
was calculated relative to the body surface area (BSA) 
and was expressed as LVM/BSA. To assess cardiac hyper-
trophy, LVMI values >134 g/m2 were adopted, as recom-
pain occurring after 16 h of running, also after 12, 36 and 
60 h of passive recovery.
Laboratory analyses
All blood samples collected during the event were immedi-
ately transported to the internal medicine clinical labora-
tory for performing biochemical analyses. Measurements 
of blood gases, electrolytes, lactate and glucose in fingertip 
capillary blood were performed using the GEM Premier 
3000 with Intelligent Quality Management (Instrumenta-
tion Laboratory, Bedford, USA). Blood morphology was 
assessed in venous blood samples (anti-coagulated with 
ethylenediaminetetraacetic acid) using an Automated He-
matology Analyzer XS-1000iTM (Sysmex, Kobe, Japan). 
Serum ferritin was measured using an Abbott Architect 
i2000 SR analyzer, serum iron (Fe) using Olympus AU400 
(Olympus, Tokyo, Japan) and plasma soluble transfer-
rin receptor (sTfR) using a BN ProSpec nephelometer 
(Siemens Healthcare Diagnostics, Erlangen, Germany). 
Serum activities of creatine kinase (CK), lactate dehydro-
genase (LDH), aspartate aminotransferase (AST), ala-
nine  aminotransferase  (ALT)  and  γ-glutamyl  transferase 
(γGT), as well as serum concentrations of total cholesterol 
(TC), high-density lipoprotein cholesterol (HDL-C), low-
density lipoprotein cholesterol (LDL-C), and triglycerides 
(TG), were measured using the clinical chemistry analyzer 
Synchron CX 9 Pro (Beckman Coulter, Krefeld, Germany). 
The intra-assay coefficients of variation (CV) for these as-
says were 5.8%, 6.70%, 5.30%, 5.60% and 3.50%, 6.10%, 
4.50%, respectively.
High-sensitivity C-reactive protein (hsCRP) was assessed in 
serum by a turbidimetric immunoassay using a Dade-Beh-
ring (Dade Berhring Marburg GmbH, Marburg, Germany) 
kit (intra assay CV: 3.45%). Serum free fatty acids (FFA) 
and glycerol contents were assessed using commercially 
available manual test kits NEFA and glycerol (GLY) (CV: 
2.7 and 1.34, respectively) from Randox Laboratories Ltd., 
Crumlin, UK. To evaluate the risk of the coronary artery 
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to the Human Performance Laboratory of the Academy of 
Physical Education for physical performance testing to as-
sess his anaerobic threshold (AnT) based on the ventilatory 
threshold (VT) [13] and peak oxygen uptake (VO2max) using 
a stationary breath-by-breath metabolic unit (MetaLyzer 3B-
R2, Cortex Biophysik GmbH, Leipzig, Germany). The test 
was performed on a model LE 200 treadmill (H/P/Cosmos 
Sports & Medical GmbH, Nussdorf, Germany), beginning 
at 6 km/h and 0° inclination, following which the treadmill 
speed was increased by 2 km/h every 3 min until reaching 
14 km/h, then kept steady but combined with a gradual in-
crease in treadmill grade by 2.5% every 3 min, in order to 
ensure similar workload increments on the subsequent steps 
of the test continued until volitional fatigue [14]. Criteria for 
termination of VO2max were voluntary exhaustion, a respira-
tory ratio ≥1.15 (RER ≥1.15) and a VO2 plateau [15].
RESULTS
The study subject’s characteristics and his 48-h race 
performance measures are presented in Tables 1 and 2. 
The ECG revealed a negative T wave in III and aVF with-
out ST segment depression or morphological abnormali-
ties. Echocardiographic examinations presented normal-
sized heart chambers, their function and a normal valvar 
structure and function (only trivial mitral and tricuspid re-
gurgitation was observed). A low resting heart rate (HR) 
and diastolic blood pressure were observed. The LV EF 
and the LV diastolic function, characterized by the peak 
early diastolic filling to peak late diastolic filling (E/A) ra-
tio, did not differ compared to references ranges. Because 
of the calcium score (193 Agatston units) in the CT of 
the heart – indicating a potential coronary artery disease – 
the authors performed an invasive coronary angiography. 
Only systolic dynamic narrowing in the eighth segment of 
the left anterior descending artery due to muscle bridging 
was noticed. Results of echocardiographic variables, rest-
ing HR, SBP/DBP, mitral inflow E- and A-wave velocities 
or the E/A ratio are presented in Table 3.
mended by Levy et al. [12]. Pulsed-wave Doppler imaging 
was used to measure the LV outflow. The mitral inflow E- 
and A-wave velocities were measured, and the E/A ratio 
was calculated along with coronary angiography.
Testing of exercise performance after the race
Three weeks following the race (i.e., 2 months before re-
turning to ultra-marathon running), the runner presented 
Table 1. Characteristics and 48-h race performance of the study 
participant during an ultra-marathon race in Katowice, Poland, 
June 20, 2010
Variable Value
Running history [years] 20






average running pace [min/km] 4:30
range II
distance [km] 8–15
average running pace [min/km] 3:45–4:00
range III
distance [km] 0.4–3





6 h of running 63.0
12 h of running 112.5
16 h of running 129.0
Running velocity [km/h]
at a marathon distance (42.195 km) 10.5
first 6 h of running 10.3
12 h of running 9.40
16 h of running 7.91
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differ significantly from the corresponding normal ranges. 
A tendency to lower K+ levels after 12 h of recovery, com-
pared to pre-race values, was observed. The blood mor-
phology remained normal. However, the serum activities 
of CK and LDH were slightly higher. The pre-race level of 
LDL-C (3.89 mmol/l) was higher compared to the refer-
ence value (3.5 mmol/l).
Analyses of the selected cardiac markers were performed re-
garding the risk of cardiac abnormalities. The blood creati-
nine, high-sensitive cardiac troponin T (hsTnT <0.014 μg/l), 
and CK myocardial band (CK-MB) were within the normal 
range (17 U/l). Contrary to expectations, the authors found 
no significant differences in the expression of these injury-
related markers in the ultra-marathon runner, either at 12-h 
distance or in response to post-race recovery.
The selected biochemical variables were first determined 
to  evaluate  the  influence  of  ultra-marathon  running  on 
the metabolic and physiological strain. The effects of 
ultra-endurance running on blood acid-base balance, 
the concentration of electrolytes, the blood glucose levels, 
the iron status, morphology, and the lipid profile are pre-
sented in Tables 4. Data concerning the ultra-marathon 
runner were compared with reference values. Laboratory 
findings were normal, in particular, blood electrolytes (i.e., 
Ca, Na, K), lactate, glucose, and the iron status did not 
Table 2. Physical performance characteristics of the study 










Weekly covered distance over the last 2 weeks 




Individual anaerobic threshold [ml/kg/min] 48
LT [%VO2max] 78








Peak serum lactate [mmol/l] 6.48
BMI – body mass index; LT – lactate threshold; VE – minute 
ventilation; VO2max – maximal oxygen uptake.
Table 3. Echocardiographic evaluation of the study participant 
during an ultra-marathon race in Katowice, Poland,  
June 20, 2010
Parameter Value
Left ventricular mass [g] 148
Left ventricular muscle mass index [g/m2] 86
Interventricular septum [mm] 9
Posterior wall thickness [mm] 9
Relative wall thickness [%] 38
Left ventricular end-diastolic diameter [mm] 48
Left ventricular end-systolic diameter [mm] 29
Left ventricular ejection fraction [%] 64
Right ventricular diastolic dimensions [mm] 28
Resting heart rate [bpm] 57








relaxation in the early diastole (the E wave); E/A – the ratio of 
the mitral inflow E- and A-waves.
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after 12 h of 
running
after 12 h of 
recovery
after 36 h of 
recovery
after 60 h of 
recovery
pH 7.35–7.45 7.40 7.50 7.47 7.43 7.44
pCO2 [mm Hg] 35–45 44 35 39 42 41
pO2 [mm Hg] 75–100 69 77 77 71 71
Standard bicarbonate HCO3
– [mmol/l] 22–26 27.3 27.3 28.4 27.9 27.8
Ca2+ [mmol/l] 1.13–1.30 1.23 1.21 1.20 1.23 1.21
Na+ [mmol/l] 135–145 143 142 140 141 139
K+ [mmol/l] 3.5–5.1 4.7 4.8 4.4 4.9 5.5
Lactate [mmol/l] 0.5–2.4 2.4 2.4 1.9 1.9 2.7
Glucose [mmol/l] 3.9–5.8 4.3 5.9 4.4 5.8 6.4
sTfR [mg/l] 0.83–1.76 1.05 1.3 0.82 0.84 0.82
Ferritin [µg/l] 22–275 48.2 65.7 – – 87.9
Fe [µmol/l] 10–30.8 25.9 7.1 27.4 26.7 21.0
sTfR/log10 ferritin index 0.63–1.8 0.624 0.715 – – 0.422
Hb [g/dl] 11.2–15.8 14.9 15.0 12.9 13.5 13.1
RBC [×106/µl] 4.0–5.8 4.78 4.81 4.11 4.35 4.18
HCT [%] 35–45 43 42 37 39 38
WBC [109/l] 4–10 6.5 15.7 11.0 6.5 5.6
Neutrophils [%] 40–80 62.2 83.9 65.5 68.2 67.8
Lymphocytes [%] 20–40 27.4 7.4 23.3 22.9 21.7
PLT [×103/µl] 130–400 226 280 221 192 230
hsCRP [mg/l] ≤5 0.16 2.0 23.3 23.0 12.1
AST [U/l] 5-40 30 55 75 88 69
ALT [U/l] 5-40 31 35 38 44 50
GGT [U/l] 18-100 23 – 21 20 23
CK [U/l] 55-370 181 1433 2345 1921 959
LDH [U/l] 120-230 185 284 249 261 247
TC [mmol/l] <5.2 6.0 – 4.8 5.2 –
LDL-C [mmol/l] <3.5 3.89 – 3.12 3.28 –
HDL-C [mmol/l] 0.7–1.7 1.5 – 1.5 1.6 –
TG [mmol/l] 0.4–1.8 1.5 – 0.5 0.8 –
Fatty acids [mmol/l] 0.1–0.9 0.402 2.977 0.447 0.402 0.432
Glycerol [μmol/l] 28–108 31.5 575.7 29.0 59.2 27.7
AIP – 0.0 – –0.477 –0.301 –
AIP – atherogenic index of plasma; ALT – alanine aminotransferase; AST – aspartate aminotransferase; Ca2+ – calcium; CK – creatine kinase; 
Fe – iron; GGT – γ-glutamyl transferase; Hb – hemoglobin; HCO3– – standard bicarbonate; HCT – hematocrit; HDL-C – high density lipoprotein 
cholesterol; hsCRP – high sensitivity C-reactive protein; K+ – potassium; LDH – lactate dehydrogenase; LDL-C – low density lipoprotein 
cholesterol; Na+ – sodium; pCO2 – partial pressure of carbon dioxide; pH – power of hydrogen; PLT – platelets; pO2 – partial pressure of oxygen; 
RBC – red blood cells; sTfR – soluble transferrin receptor; TC – total cholesterol; TG – triglycerides; WBC – white blood cells.
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hypothesized that training-induced bradycardia, atrial 
dilatation and, possibly, atrial premature beats (Coumel’s 
triangle) are the main arrhythmogenic contributors to ex-
ercise-induced atrial fibrillation [17].
Findings have suggested an increased risk of atrial fibro-
sis, possibly due to cumulative minor structural damage 
after each exercise bout. These adverse cardiovascular 
consequences may be associated with abnormal release 
of cardiac biomarkers (e.g., cardiac troponin T [cTnT], 
CK-MB, myoglobin, and N-terminal prohormone of brain 
natriuretic peptide [NTproBNP]) [10]. The main cardiac 
biomarkers have different times of reaching maximal 
concentrations after a run, compared to pre-race values. 
Therefore, in this case study, the authors did not analyze 
the dynamic of biomarkers secretion during the ultra-
marathon race, but only after the time point of the chest 
pain.
Performance characteristics of the runner
There is no doubt that the runner was a highly special-
ized long-distance runner with >20 years of regular run-
ning experience, who has already participated in 55 ultra-
marathon races. In the athlete’s medical history, there was 
no hint of cardiovascular diseases. Before the incident, his 
typical peak training mileage was 120–160 km/week, while 
within 2 weeks preceding the race (the tapering period), 
the training load was lowered to 114 and 84 km/week, sep-
arated by a 2-day recovery. The runner is the World Cham-
pionships bronze medalist in the 48-h race with the Polish 
record of 370 km 381 m, and a silver (2008) and bronze 
(2009) medalist at the Polish Championships in the 24-h 
race. The high level of his running performance is reflect-
ed by his high VO2max and lactate threshold expressed as 
%VO2max (Table 4), as well as by his capacity to maintain 
a stable running velocity (10.5 km/h) over the traditional 
marathon distance covered in 3:58 h, only slightly reduced 
(10.3 km/h) over the whole 12-h period (Table 1), and also 
by the distance covered (63.0 and 112.5 km) and the run-
DISCUSSION
In this case report, the authors describe different meta-
bolic and cardiac characteristics of an ultra-marathon run-
ner who had to stop during a 48-h ultra-marathon race 
due to acute chest pain. The most important aspect in this 
case study is the discovery that no severe cardiac problems 
were detected using extensive and invasive cardiac exami-
nations. According to the echocardiographic examination, 
the final diagnosis suggested that the cardiac incident was 
due to ischemic heart disease. The echocardiographic ex-
aminations of the LV and RV dimensions performed after 
completion of the race showed normal values (Table 3).
However, further findings were a mild mitral regurgitation 
and a tricuspid regurgitation, as well as a mixed hyperlip-
idemia. In the interview, stenocardial ailments during in-
tense physical exertion appeared, as well as negative T wa-
ves in III and aVF in the ECG. In the echocardiography, 
no segmental or global shrinkage disorders could be de-
tected. In the CT of the heart, a calcium score of 193 AU 
was measured, indicating the moderate risk of coronary 
events in the future. In the coronary angiography, a muscle 
bridge appeared in the course of the anterior descending 
artery (the eighth left anterior descending artery segment) 
narrowing the artery (40–50%) uncritically during con-
traction. Based on the results of examinations and tests, 
the cardiologists advised the runner against participating 
in athletic events.
The increase in the popularity of ultra-marathon running 
participation contributes to the increase in the number of 
reports on cardiac dysfunction in elite as well as amateur 
athletes. Prolonged exertion might have serious patho-
physiological consequences, including pathological heart 
hypertrophy, cardiovascular complications and a higher 
risk of exercise-induced arrhythmogenic sudden cardiac 
death  [16].  Epidemiological  studies  have  confirmed  an 
association between very intense endurance training and 
a 3–8-fold increased risk of atrial fibrillation in individuals 
without coexisting cardiovascular risk factors. It has been 
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pant’s iron status based on measures of serum iron, serum 
ferritin, sTfR and the sTfR/log10 ferritin index. In spite of 
a marked increase in the absolute value of ferritin, a slight 
increase in sTfR and a marked decrease in serum iron, 
the levels of the sTfR/log10 ferritin index were within nor-
mal ranges [21] after 12 h of running, suggesting a nor-
mal iron status in the study participant (Table 2). Of note, 
these findings are in line with those reported by Kaspro-
wicz et al. [22] for middle-aged runners participating in 
a 100-km ultra-marathon race.
The most important are changes in the hematological 
and metabolic parameters induced by prolonged strenu-
ous exercise. The pre-race hemoglobin (Hb) and hema-
tocrit (HCT) levels were not significantly affected follow-
ing  the first 12 h of  the  race, but  they were  significantly 
reduced during the recovery period. The platelet count 
(PLT) rose markedly but returned to baseline during 
the recovery. As expected, finishing a distance of 112.5 km 
during 12 h of the race led to leukocytosis evidenced by 
a high increase in the white blood cell (WBC) counts with 
most marked neutrophilia and lymphocytopenia. Similar 
response to prolonged strenuous exercise (e.g., a classic 
marathon, or 24-h and 48-h ultra-marathon races) was re-
ported by other authors [10,18,23].
One may presume that this effect is mediated by an in-
creased secretion of cortisol and a reduction of neutrophil 
degranulation [24]. Marked increases in the serum activi-
ties of CK (8-fold) and AST (nearly 2-fold), recorded af-
ter  12  h  of  running,  reflect  the  extent  of  the  leakage  of 
tissue enzyme proteins into the circulation due to muscle 
injury arising  from myofibrillar disruption [25].  It  is well 
documented that intense long-term physical strain, such 
as running a marathon, also induces an acute phase of in-
flammatory reaction, as evidenced by a delayed  increase 
in the hsCRP released from the liver [26], and such a re-
sponse, continued during the recovery, was recorded in 
the study participant (Table 3). It is worth to stress that 
similar  significant  post-race  increases  in  the  levels  of 
ning speed (10.5 and 9.40 km/h) during the first 6 and 12 h 
of the race (Table 1).
It is worth noting that the above mentioned data are better 
than those reported previously [10,18] in amateur run-
ners participating in 24-h or 48-h ultra-marathon races 
held on the same site. In addition, the values of VO2max 
and LT recorded in the study participant (Table 4) matched 
those found in elite endurance athletes [19]. However, in 
this individual case, a marked drop in actual running ve-
locity to 4.13 km/h during the subsequent hours, due to 
the onset of acute chest pain, forced the participant 
to make the decision to drop out of the race.
The better insight into the metabolic response to exercise-
induced physical strain may be provided by the analysis of 
changes in biochemical markers (Tables 2 and 3). The pre-
race levels of capillary blood gases, electrolytes and indi-
ces of the acid-base balance were within normal ranges, 
but their marked changes were observed after 12 h of run-
ning. Hyperventilation resulting from sustained running 
led to hyperventilation-induced hypocapnic alkalosis [20], 
evidenced by pH increased by 0.1 units, and marked hy-
pocapnia associated with a 20% decrease in pCO2. This 
was accompanied by only minor changes in the plasma 
electrolyte levels, with no evidence of hyponatremia or 
hyperkalemia. The stable rest and post-12 h running 
plasma lactate contents support the notion that the mean 
running speed maintained at this distance (10.3 km/h) did 
not exceed the level corresponding to that reached at LT 
(12 km/h) in the incremental running test (Table 2). More-
over, a slightly elevated glucose level recorded after 12 h 
of running, though still within the normal range, confirms 
the presumption of the adequate carbohydrate supply 
during the race due to providing free access to food to all 
competitors.
Taking into account that high-level endurance athletes, 
such as ultra-marathon runners, are at a higher risk of iron 
deficiency,  the  symptoms of which can be confused with 
those of overtraining, the authors evaluated the partici-
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races. He  successfully finished 40 marathons held  in  the 
period of June 23 – August 3, 2012 in 42 cities in Poland, 
within the framework of a national project “42 marathons 
in 42 days,” with an average finishing time of 3.44:43 h.
In addition, obviously his most important sports achieve-
ments were the completion of 2 extreme running pilgrim-
ages from his home town (Ruda Śląska, Poland) to Vati-
can, undertaken in 2013 in tribute to Pope John Paul II on 
the thirty-fifth anniversary of his election, and to Santiago 
de Compostela in Spain in 2016. During these pilgrim-
ages, he completed the distances of 1590 km in 24 days 
(with an average daily distance of 66.3 km/d) and 2973 km 
in 43 days (with an average daily distance of 69.1 km/d). 
The above mentioned athletic achievements support 
the notion of his high physical performance maintained 
>6 years following his cardiac incident manifested dur-
ing the 48-h race, and provide strong support for findings 
from other studies [28] that the chronic accumulation of 
acute exercise stress may lead to a healthy, physiological 
adaptation in the heart.
The heart in ultra-marathon running
It is well-known that participating in an ultra-marathon 
race leads to immense stress on the athlete’s heart [4], 
inducing changes in cardiac biomarkers in echocardio-
graphic findings [10]. It is also well-known that marathon 
running can lead to cardiac arrest and death [29]. Ultra-
marathon running, however, does not seem to increase 
the risk of cardiac arrest and death since the authors found 
no  case  report  or  field  study  regarding  cardiac  death  in 
ultra-marathon running or ultra-endurance performance. 
This might be due to the fact that ultra-marathon runners 
compete first  in marathons before  they  change  to ultra-
marathon running [4].
For the development of multiple cardiac abnormalities 
(e.g., fibrosis, atrial arrhythmias, ventricular arrhythmias, 
and sudden death), associated with marathon and ultra-
marathon running, the term “Phidippides cardiomyopa-
hsCRP were observed in 7 male amateur runners who 
successfully completed the same event (i.e., a 48-h ultra-
marathon race held in the same place) [10].
Another important issue to resolve in this study was to 
evaluate the impact of the ultra-endurance effort on fat 
metabolism. The most  significant were  increases  in  free 
fatty acids (7.5-fold) and glycerol (18-fold) observed af-
ter finishing  the distance covered over a 12-h race, both 
of which returned to baseline (pre-race) levels following 
12-h recovery. This finding, on the one hand, strongly sup-
ports the presumption of a substantial mobilization of 
systemic fat stores during prolonged muscular work and 
an increased supply of FFA for intramuscular fat oxida-
tion. On the other hand, the elevated levels of free fatty 
acids may also lead to depression of the inotropic state 
and an impairment of the heart function [27], as observed 
in the study participant. As TC, LDL-C, HDL-C and TG 
were not measured following 12 h of running, the authors 
could only comment on their levels assessed following 
the recovery. The most favorable changes in the lipid pro-
file included a 3-fold decrease in TG and a marked decline 
in the levels of the atherogenic index of plasma (AIP) [11] 
providing indirect, but reliable information on the low 
plasma content of the most atherogenic small dense LDL 
(sdLDL) particles.
A follow-up history of the athlete’s sports achievements
After dropping out of the ultra-marathon race due to car-
diac problems mentioned above, and 2 months spent on re-
gaining his physical and psychological well-being, the ath-
lete resumed his training program. His weekly training 
plan, which was based on the assumption that the distance 
covered daily in the outdoor conditions should match his 
current physical capacity and environmental conditions, is 
limited to 40 km daily with 1- or 2-day break over a week 
to ensure optimal recovery. So, excluding his previous 
participation in 55 ultra-marathon races, it is worth noting 
that since 2010 he competed in 11 other ultra-marathon 
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the cardiac problems he had experienced during the ultra-
marathon race did not prevent him from being active in 
sport. It needs to be noted, however, that as a dynamic 
systolic narrowing in the eighth segment of the left an-
terior descending artery, due to a muscle bridge, can be 
life-threatening. Therefore, cardiologists recommend that 
individuals with similar cardiac disorders should avoid in-
tense exercise.
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